← Back to All US Stocks

Adastra Holdings Ltd. (XTXXF) Fundamental Analysis & AI Grade 2026

XTXXF OTC Pharmaceutical Preparations A1 CIK: 0001891512
Recently Updated • Analysis: May 28, 2026 • SEC Data: 2026-05-28

Adastra Holdings Ltd. (XTXXF) Financial Metrics & Key Ratios

Revenue
N/A
Net Income
N/A
EPS (Diluted)
$0.00
Free Cash Flow
N/A
Total Assets
N/A
Cash Position
N/A

💡 AI Analyst Insight

The current ratio below 1.0x warrants monitoring of short-term liquidity.

XTXXF Profit Margin, ROE & Profitability Analysis

Gross Margin N/A
Operating Margin N/A
Net Margin N/A
ROE N/A
ROA N/A
FCF Margin N/A

XTXXF vs Healthcare Sector: How Adastra Holdings Ltd. Compares

How Adastra Holdings Ltd. compares to Healthcare sector averages

Net Margin
XTXXF 0.0%
vs
Sector Avg 12.0%
XTXXF Sector
ROE
XTXXF 0.0%
vs
Sector Avg 15.0%
XTXXF Sector
Current Ratio
XTXXF 0.0x
vs
Sector Avg 2.0x
XTXXF Sector
Debt/Equity
XTXXF 0.0x
vs
Sector Avg 0.6x
XTXXF Sector

Sector benchmarks are approximate industry averages. Actual sector performance may vary.

Is Adastra Holdings Ltd. Stock Overvalued? XTXXF Valuation Analysis 2026

Based on fundamental analysis, Adastra Holdings Ltd. has mixed fundamental signals relative to the Healthcare sector in 2026.

Return on Equity
N/A
Sector avg: 15%
Net Profit Margin
N/A
Sector avg: 12%
Revenue Growth
N/A
Year-over-year
Debt/Equity
N/A
Sector avg: 0.6x

Note: This is a fundamental analysis based on SEC filings. For P/E ratio, price targets, and market-based valuation, consult financial data providers. This is not investment advice.

Adastra Holdings Ltd. Balance Sheet: XTXXF Debt, Cash & Liquidity

Current Ratio
N/A
Quick Ratio
N/A
Debt/Equity
N/A
Debt/Assets
0.0%
Interest Coverage
N/A
Long-term Debt
N/A

XTXXF Revenue Growth, EPS Growth & YoY Performance

Revenue Growth
N/A
Year-over-year
Net Income Growth
N/A
Year-over-year
EPS Growth
N/A
Earnings per share
FCF Margin
N/A
Free cash flow / Revenue

XTXXF SEC Filings: Latest 10-K & 10-Q Analysis

Access official SEC EDGAR filings for Adastra Holdings Ltd. (CIK: 0001891512)

Frequently Asked Questions about XTXXF

What is the AI rating for XTXXF?

Adastra Holdings Ltd. (XTXXF) has an AI grade of N/A with 0% confidence, based on fundamental analysis of SEC EDGAR filings.

What are XTXXF's key strengths?

Claude: Analysis in progress.

What are the risks of investing in XTXXF?

Claude: Analysis in progress.

What is XTXXF's revenue and growth?

Adastra Holdings Ltd. reported revenue of N/A.

Does XTXXF pay dividends?

Adastra Holdings Ltd. does not currently pay dividends.

Where can I find XTXXF SEC filings?

Official SEC filings for Adastra Holdings Ltd. (CIK: 0001891512) including 10-K, 10-Q, and 8-K reports are available on SEC EDGAR.

What is XTXXF's EPS?

Adastra Holdings Ltd. has a diluted EPS of $0.00.

How is the AI analysis conducted?

Two independent AI systems — Claude (Anthropic) and ChatGPT (OpenAI) — analyze SEC EDGAR filings including 10-K annual reports and 10-Q quarterly reports. Each AI evaluates financial health, profitability ratios, balance sheet strength, and growth metrics. The combined grade reflects both perspectives for balanced insights.

What is XTXXF's fundamental grade?

Based on our AI fundamental analysis in May 2026, Adastra Holdings Ltd. has a N/A grade with 0% confidence. Review the strengths and risks sections above for full context. This is not investment advice.

Is XTXXF stock overvalued or undervalued?

Valuation metrics for XTXXF: ROE of N/A (sector avg: 15%), net margin of N/A (sector avg: 12%). Compare these metrics with sector averages to assess valuation.

What is XTXXF's AI grade for 2026?

Our dual AI analysis gives Adastra Holdings Ltd. a combined N/A grade for 2026. Revenue is data pending, with profitability at or below sector average. Always conduct your own research.

What is XTXXF's free cash flow?

Adastra Holdings Ltd.'s operating cash flow is N/A, with capital expenditures of N/A.

How does XTXXF compare to other Healthcare stocks?

Vs Healthcare sector averages: Net margin N/A (avg: 12%), ROE N/A (avg: 15%), current ratio N/A (avg: 2).

Top Rated Stocks
AAPL 92% MSFT 92% FAST 92% ANET 88% RDDT 88% KNSL 88% MGRE 88% FIZZ 88% DECK 87% NVDA 87%
Sector: All Healthcare Stocks →
Disclaimer: This analysis is generated by Claude AI (Anthropic) and ChatGPT (OpenAI) based on publicly available SEC EDGAR filings. It does not include stock price data and should not be considered financial advice. All fundamental data is sourced from SEC public domain filings. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.
Data Source: SEC EDGAR | Analysis Date: May 28, 2026 | Data as of: 2026-05-28 | Powered by Claude AI